Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 500

1.

Ovarian preservation in stage I low-grade endometrial stromal sarcomas.

Li AJ, Giuntoli RL 2nd, Drake R, Byun SY, Rojas F, Barbuto D, Klipfel N, Edmonds P, Miller DS, Karlan BY.

Obstet Gynecol. 2005 Dec;106(6):1304-8.

PMID:
16319256
2.

Endometrial stromal sarcoma: analysis of treatment failures and survival.

Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A, Lissoni A, Losa G, Fanucchi A.

Gynecol Oncol. 1996 Nov;63(2):247-53.

PMID:
8910635
3.

Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma?

Barney B, Tward JD, Skidmore T, Gaffney DK.

Int J Gynecol Cancer. 2009 Oct;19(7):1232-8. doi: 10.1111/IGC.0b013e3181b33c9a.

PMID:
19823060
4.

Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.

Weitmann HD, Kucera H, Knocke TH, Pötter R.

Wien Klin Wochenschr. 2002 Jan 15;114(1-2):44-9.

PMID:
12407935
5.

Low-grade endometrial stromal sarcoma: hormonal aspects.

Chu MC, Mor G, Lim C, Zheng W, Parkash V, Schwartz PE.

Gynecol Oncol. 2003 Jul;90(1):170-6.

PMID:
12821359
6.

Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma.

Shah JP, Bryant CS, Kumar S, Ali-Fehmi R, Malone JM Jr, Morris RT.

Obstet Gynecol. 2008 Nov;112(5):1102-8. doi: 10.1097/AOG.0b013e31818aa89a.

PMID:
18978112
7.

A multi-institutional review of outcomes of endometrial stromal sarcoma.

Leath CA 3rd, Huh WK, Hyde J Jr, Cohn DE, Resnick KE, Taylor NP, Powell MA, Mutch DG, Bradley WH, Geller MA, Argenta PA, Gold MA.

Gynecol Oncol. 2007 Jun;105(3):630-4. Epub 2007 Feb 23.

PMID:
17320937
8.

Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.

Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Mayerhofer S, Czerwenka K, Leodolter S, Kainz C, Mayerhofer K.

Gynecol Oncol. 2001 May;81(2):160-5.

PMID:
11330943
9.

Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?

Garg G, Shah JP, Toy EP, Bryant CS, Kumar S, Morris RT.

Gynecol Oncol. 2010 Jul;118(1):8-13. doi: 10.1016/j.ygyno.2010.04.008. Epub 2010 May 5.

PMID:
20447684
10.

Ovarian preservation and staging in reproductive-age endometrial cancer patients.

Richter CE, Qian B, Martel M, Yu H, Azodi M, Rutherford TJ, Schwartz PE.

Gynecol Oncol. 2009 Jul;114(1):99-104. doi: 10.1016/j.ygyno.2009.03.032. Epub 2009 May 1.

PMID:
19410280
11.

Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?

Feng W, Hua K, Malpica A, Zhou X, Baak JP.

Int J Gynecol Cancer. 2013 Mar;23(3):488-93. doi: 10.1097/IGC.0b013e318247aa14.

PMID:
23435438
12.

Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.

Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF, Boente MP.

Gynecol Oncol. 2004 Dec;95(3):632-6.

PMID:
15581975
13.

Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.

Papanikolaou A, Kalogiannidis I, Goutzioulis M, Misailidou D, Makedos A, Vergote I, Makedos G.

Arch Gynecol Obstet. 2006 May;274(2):91-6. Epub 2006 Mar 4.

PMID:
16518607
14.

Low-grade endometrial stromal sarcoma: a single center's experience with 22 cases.

Kim WY, Lee JW, Choi CH, Kang H, Kim TJ, Kim BG, Lee JH, Bae DS.

Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1084-9. doi: 10.1111/j.1525-1438.2007.01159.x. Epub 2007 Dec 27.

PMID:
18179547
15.

[Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].

Ma SK, Zhang HT, Wu LY, Liu LY, Li B.

Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):74-8. Chinese.

PMID:
17575701
16.

Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.

Liokumovich P, Goldberg I, Davidson B, Gotlieb WH, Zahavi T, Ben-Baruch G, Reder I, Kopolovic J.

J Clin Pathol. 1999 Mar;52(3):198-202.

17.

A retrospective study of 27 ovarian tumors of low malignant potential.

Demeter A, Csapó Z, Szánthó A, Bálega J, Sipos N, Papp Z.

Eur J Gynaecol Oncol. 2002;23(5):415-8.

PMID:
12440814
18.

A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.

Secord AA, Havrilesky LJ, O'Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA.

Gynecol Oncol. 2009 Sep;114(3):442-7. doi: 10.1016/j.ygyno.2009.06.005. Epub 2009 Jun 26.

PMID:
19560193
19.

Safety of ovarian preservation in premenopausal women with endometrial cancer.

Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ.

J Clin Oncol. 2009 Mar 10;27(8):1214-9. doi: 10.1200/JCO.2008.19.8150. Epub 2009 Jan 26.

PMID:
19171707
20.

Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue.

Burke C, Hickey K.

Obstet Gynecol. 2004 Nov;104(5 Pt 2):1182-4.

PMID:
15516445

Supplemental Content

Support Center